Xencor Delays IPO
socalTECH
NOVEMBER 18, 2013
Monrovia-based Xencor , the developer of biopharmaceutical technology headed by Bassill Dahiyat, delayed its IPO Friday, citing poor market conditions for the offering. The company had hoped to IPO on the NASDAQ Global Market. The company is backed by MedImmune Ventures, HealthCare Ventures, and others. READ MORE>>.
Let's personalize your content